2020
DOI: 10.1007/s00430-020-00674-2
|View full text |Cite
|
Sign up to set email alerts
|

Autoimmunity to tetraspanin-7 in type 1 diabetes

Abstract: Type 1 diabetes is an autoimmune disease whereby components of insulin-secreting pancreatic beta cells are targeted by the adaptive immune system leading to the destruction of these cells and insulin deficiency. There is much interest in the development of antigen-specific immune intervention as an approach to prevent disease development in individuals identified as being at risk of disease. It is now recognised that there are multiple targets of the autoimmune response in type 1 diabetes, the most recently id… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
14
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(15 citation statements)
references
References 56 publications
0
14
0
1
Order By: Relevance
“…Mutations in Tspan7 have been associated with X‐linked intellectual disability, 36 and Tspan7 has been implicated in the development of the nervous system and synaptic function 37 . Thus, the role of Tspan7 has been reported primarily in relation to its function in the brain, however, its function in metabolism has also been suggested recently 38–42 . TSPAN7 regulates insulin secretion levels by defining a set‐point for glucose‐stimulated insulin secretion, 39 and TSPAN7 is a target of autoantibodies in type 1 diabetes 40–42 .…”
Section: Discussionmentioning
confidence: 99%
“…Mutations in Tspan7 have been associated with X‐linked intellectual disability, 36 and Tspan7 has been implicated in the development of the nervous system and synaptic function 37 . Thus, the role of Tspan7 has been reported primarily in relation to its function in the brain, however, its function in metabolism has also been suggested recently 38–42 . TSPAN7 regulates insulin secretion levels by defining a set‐point for glucose‐stimulated insulin secretion, 39 and TSPAN7 is a target of autoantibodies in type 1 diabetes 40–42 .…”
Section: Discussionmentioning
confidence: 99%
“…Their enzyme activity has also been linked to the generation of autoantigens in T1D [ 33 , 55 , 56 ]. These enzymes, upon activation, can modify constitutive β-cell proteins such as chromogranin A [ 57 , 58 ], preproinsulin [ 59 ], TSPAN7 [ 60 , 61 ], GAD65 [ 62 , 63 ], and ZnT8 [ 64 ], etc. Thus, the loss of calcium homeostasis during ER stress leads to aberrant post-translational modifications of β-cell proteins.…”
Section: Loss Of Ca ++ Homeostasis As a Mechanism ...mentioning
confidence: 99%
“…Der Entwicklung des Typ 1 Diabetes liegt eine zellulär-mediierte Autoimmundestruktion der pankreatischen beta-Zelle zugrunde [ 1 , 2 ]. Die Autoimmunmarker inkludieren Inselzellantikörper, GAD65 Antikörper, Insulin Antikörper, Antikörper gegenüber Tyrosinphosphatase IA‑2 und IA-2beta, sowie Antikörper gegenüber Zinktransporter 8 (ZnT8) und Tetraspanin‑7 [ 1 , 5 , 6 ].…”
unclassified